Somehow LDL-cholesterol has come up in this thread about inflammation. The article here offers a highly speculative opinion regarding the role of inflammation across many diseases. The luminaries in cardiology cited in this article ran trials which many of us consider to show that, rather than inflammation being important, any reason to start statins is a good reason. The genetic data currently supports very little r…
I think this is a bit unkind: > dismissed in a pseudo-intellectual manner by people who know a lot (just not about the subject at hand). I'm the one who's potentially sick here, and this (perhaps wrongly) smacks of appeal to authority. What I absolutely don't want to do is disregard medical opinion, but neither am I inclined to abdicate all responsibility for my own health and well being. > The genetic data currently…
As for studies that I find instructive, here are a few:
People with loss of function mutations in PCSK9 have lower LDL-cholesterol. These people have an even lower risk of ischemic heart disease than you would expect based on the degree of LDL-cholesterol lowering. [1]
Mendelian randomization demonstrates that genetic scores for LDL cholesterol associate with reduced risk of myocardial infarction (suggesting causality, since cholesterol doesn't reverse-cause a genotype).[2]
IMPROVE-IT showed that a non-statin medication (ezetemibe) added to a statin regimen further reduced the risk of second heart attacks after suffering a first heart attack. This is probably the clearest experimental evidence to date that suggest it's not only statins that reduce cardiovascular risk, but LDL-cholesterol reducing agents more generally that lead to reduced risk of heart attack. [3]
This is a very contemporary summary of genetic and clinical trial data; there is a wealth of older data that I won't get into.
1 = http://www.nejm.org/doi/full/10.1056/NEJMoa054013